Drs. Thomas Stinchcombe and Anne S. Tsao discuss practice-changing presentations in lung cancer and mesothelioma from the ASCO 2018 annual meeting in Chicago.
Review key data on urothelial carcinoma, RCC, and prostate cancer from ASCO 2018 with Daniel P. Petrylak, MD, and Elizabeth R. Plimack, MD, MS.
Short CME/CE-certified video from H. Jack West, MD, on optimal treatment of metastatic lung adenocarcinoma with no detectable tumor PD-L1 expression.
Expert commentary from Edward B. Garon, MD, MS, on managing NSCLC that has progressed on checkpoint inhibitors in unresectable stage III or first-line therapy for metastatic disease.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.